PARP1 and cancer: Due to the predominant function of PARP1 in DNA repair, its inhibition appeared as the strategy of choice in various forms of cancer to potentialize the cytotoxic action of chemotherapy and radiotherapy or to selectively kill tumors with dysfunctional repair [26–28].